RNAseq identification of FISH-cryptic BCL6::TP63 rearrangement in ALK-negative anaplastic large-cell lymphoma.
作者信息
Ahmed Nada, Ketterling Rhett P, Nowakowski Grzegorz S, Dasari Surendra, Feldman Andrew L
机构信息
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
出版信息
Histopathology. 2022 Aug;81(2):275-278. doi: 10.1111/his.14674. Epub 2022 May 27.
Abstract
摘要
相似文献
1
RNAseq identification of FISH-cryptic BCL6::TP63 rearrangement in ALK-negative anaplastic large-cell lymphoma.
Histopathology. 2022 Aug;81(2):275-278. doi: 10.1111/his.14674. Epub 2022 May 27.
2
Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma.
Biomark Med. 2015;9(8):719-22. doi: 10.2217/BMM.15.37. Epub 2015 Jul 30.
3
[Detection of chromosomal translocations of DUSP22 and TP63 in ALK-negative anaplastic large cell lymphoma by fluorescence in situ hybridization and related clinical relevance].
Zhonghua Bing Li Xue Za Zhi. 2019 Oct 8;48(10):791-795. doi: 10.3760/cma.j.issn.0529-5807.2019.10.008.
4
Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement.
Br J Haematol. 2021 Jan;192(1):e17-e21. doi: 10.1111/bjh.17169. Epub 2020 Nov 20.
5
"Double-hit" of DUSP22 and TP63 rearrangements in anaplastic large cell lymphoma, ALK-negative.
Blood. 2020 Feb 27;135(9):700. doi: 10.1182/blood.2019004164.
6
Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping.
Hum Pathol. 2017 Jun;64:19-27. doi: 10.1016/j.humpath.2017.01.003. Epub 2017 Jan 30.
7
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.
Blood. 2014 Aug 28;124(9):1473-80. doi: 10.1182/blood-2014-04-571091. Epub 2014 Jun 3.
8
Co-occurring rearrangements of and define a rare genetic subset of ALK-negative anaplastic large cell lymphoma with inferior survival outcomes.
Leuk Lymphoma. 2022 Feb;63(2):506-508. doi: 10.1080/10428194.2021.1984457. Epub 2021 Oct 6.
9
Fluorescence in-situ hybridisation for TP63 rearrangements in T cell lymphomas: single-site experience of 470 patients and implications for clinical testing.
Histopathology. 2020 Feb;76(3):481-485. doi: 10.1111/his.14005. Epub 2020 Jan 17.
10
and rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study.
Blood. 2017 Jul 27;130(4):554-557. doi: 10.1182/blood-2016-12-755496. Epub 2017 May 18.
引用本文的文献
1
Establishment and characterization of a novel patient-derived TP63-rearranged anaplastic large-cell lymphoma model PTCL-S1.
Hum Cell. 2025 Jul 26;38(5):135. doi: 10.1007/s13577-025-01264-1.
2
Identification of cryptic breakpoints through single-tube long fragment read whole genome sequencing based on preimplantation genetic testing.
NPJ Genom Med. 2025 Feb 21;10(1):15. doi: 10.1038/s41525-025-00471-x.
3
Anaplastic large cell lymphomas with equivocal DUSP22 FISH results: recommendations for clinical reporting and diagnostic evaluation.
Hum Pathol. 2023 Nov;141:6-14. doi: 10.1016/j.humpath.2023.08.007. Epub 2023 Aug 24.
4
ALK-negative anaplastic large cell lymphoma with rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study.
Haematologica. 2023 Jun 1;108(6):1590-1603. doi: 10.3324/haematol.2022.281442.
5
Genomic Aberrations Generate Fusion Gene FOXK2::TP63 and Activate NFKB1 in Cutaneous T-Cell Lymphoma.
Biomedicines. 2022 Aug 21;10(8):2038. doi: 10.3390/biomedicines10082038.
本文引用的文献
1
Fluorescence in-situ hybridisation for TP63 rearrangements in T cell lymphomas: single-site experience of 470 patients and implications for clinical testing.
Histopathology. 2020 Feb;76(3):481-485. doi: 10.1111/his.14005. Epub 2020 Jan 17.
2
The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH.
Blood. 2019 Oct 31;134(18):1528-1532. doi: 10.1182/blood.2019002600.
3
Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with rearrangements.
Blood. 2018 Sep 27;132(13):1386-1398. doi: 10.1182/blood-2018-03-838524. Epub 2018 Aug 9.
4
Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping.
Hum Pathol. 2017 Jun;64:19-27. doi: 10.1016/j.humpath.2017.01.003. Epub 2017 Jan 30.
5
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.
Blood. 2014 Aug 28;124(9):1473-80. doi: 10.1182/blood-2014-04-571091. Epub 2014 Jun 3.
6
Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas.
Blood. 2012 Sep 13;120(11):2280-9. doi: 10.1182/blood-2012-03-419937. Epub 2012 Aug 1.
Zotero 插件